Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

VWF antibody (AA 845-949) (Biotin)

This Mouse Monoclonal antibody specifically detects VWF in IHC and IHC (fp). It exhibits reactivity toward Human.
Catalog No. ABIN7662013

Quick Overview for VWF antibody (AA 845-949) (Biotin) (ABIN7662013)

Target

See all VWF Antibodies
VWF (Von Willebrand Factor (VWF))

Reactivity

  • 225
  • 44
  • 32
  • 12
  • 7
  • 6
  • 2
  • 1
Human

Host

  • 132
  • 131
  • 13
  • 7
  • 1
  • 1
  • 1
Mouse

Clonality

  • 158
  • 123
  • 2
Monoclonal

Conjugate

  • 134
  • 28
  • 18
  • 11
  • 9
  • 9
  • 9
  • 9
  • 9
  • 9
  • 7
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This VWF antibody is conjugated to Biotin

Application

  • 187
  • 162
  • 80
  • 74
  • 63
  • 55
  • 49
  • 46
  • 25
  • 16
  • 16
  • 15
  • 9
  • 9
  • 8
  • 6
  • 6
  • 5
  • 5
  • 4
  • 4
  • 3
  • 3
  • 3
  • 1
  • 1
Immunohistochemistry (IHC), Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections) (IHC (fp))

Clone

IIIE2-34
  • Binding Specificity

    • 55
    • 21
    • 16
    • 11
    • 9
    • 8
    • 6
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 845-949

    Purpose

    von Willebrand Factor / Factor VIII Related-Ag (Endothelial Marker)(IIIE2.34), Biotin conjugate

    Characteristics

    von Willebrand Factor (vWF) is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi's sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen.

    Immunogen

    Recombinant human vWF fragment spanning aa 845-949

    Isotype

    IgG1, kappa
  • Application Notes

    Higher concentration may be required for direct detection using primary antibody conjugates than for indirect detection with secondary antibody. Immunohistochemistry (formalin-fixed): 0.5-1.0 μg/mL for 30 minutes at RT. Immunoprecipitation: 0.5-1 μg/500 μg protein lysate. Western blot: 0.5-1.0 μg/mL. Flow cytometry: 0.5-1 μg/million cells. Immunofluorescence: 0.5-1 μg/mL. Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM citrate buffer, pH 6.0, for 10-20 minutes followed by cooling at RT for 20 minutes. Optimal dilution for a specific application should be determined by user

    Comment

    Positive Control: HUVEC cells. Tonsil.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    0.1 mg/mL

    Buffer

    PBS, 0.1 % BSA, 0.05 % azide

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C

    Storage Comment

    Stable at room temperature or 37°C for 7 days.

    Store at 2 to 8°C. Protect fluorescent conjugates from light

    Expiry Date

    24 months
  • Target

    VWF (Von Willebrand Factor (VWF))

    Alternative Name

    Von Willebrand Factor

    Background

    Synonyms: Coagulation Factor VIII, Factor VIII Related Antigen, F8VWF, von Willebrand Antigen 2, von Willebrand Disease (vWD)

    Gene Symbol: VWF

    Tissue Expression: Endothelial cells

    Molecular Weight

    250 kDa

    Gene ID

    7450

    UniProt

    P04275
You are here:
Chat with us!